Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

CCL2/CCR2 signaling elicits itch- and pain-like behavior in a murine model of allergic contact dermatitis.

Jiang H, Cui H, Wang T, Shimada SG, Sun R, Tan Z, Ma C, LaMotte RH.

Brain Behav Immun. 2019 Apr 11. pii: S0889-1591(18)31210-8. doi: 10.1016/j.bbi.2019.04.026. [Epub ahead of print]

PMID:
30981714
2.

Immune characteristics correlating with HSV-1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes.

McTavish H, Zerebiec KW, Zeller JC, Shekels LL, Matson MA, Kren BT.

Immun Inflamm Dis. 2019 Mar;7(1):22-40. doi: 10.1002/iid3.241. Epub 2019 Feb 12.

3.

Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.

Lee S, Kim BJ, Lee YB, Lee WS.

JAMA Dermatol. 2018 Oct 1;154(10):1145-1151. doi: 10.1001/jamadermatol.2018.2312.

PMID:
30073292
4.

Development and validation of a liquid chromatographic method for the analysis of squaric acid dibutyl ester and its impurities.

Mansour MF, Zhu P, Van Schepdael A, Adams E.

J Pharm Biomed Anal. 2017 Jul 15;141:165-172. doi: 10.1016/j.jpba.2017.04.022. Epub 2017 Apr 18.

PMID:
28448885
5.

Cl- channel is required for CXCL10-induced neuronal activation and itch response in a murine model of allergic contact dermatitis.

Qu L, Fu K, Shimada SG, LaMotte RH.

J Neurophysiol. 2017 Jul 1;118(1):619-624. doi: 10.1152/jn.00187.2017. Epub 2017 Apr 26.

6.

Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.

Chen CA, Carlberg V, Kroshinsky D.

Pediatr Dermatol. 2017 Jan;34(1):e44-e46. doi: 10.1111/pde.12993. Epub 2016 Oct 4.

PMID:
27699860
7.

Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.

Guerra L, Pacifico V, Calabresi V, De Luca N, Castiglia D, Angelo C, Zambruno G, Di Zenzo G.

Br J Dermatol. 2017 Feb;176(2):491-494. doi: 10.1111/bjd.14764. Epub 2016 Dec 8.

PMID:
27208509
8.

Modified immunotherapy for alopecia areata.

Yoshimasu T, Furukawa F.

Autoimmun Rev. 2016 Jul;15(7):664-7. doi: 10.1016/j.autrev.2016.02.021. Epub 2016 Feb 27. Review.

PMID:
26932732
9.

Allergic Contact Dermatitis: A Model of Inflammatory Itch and Pain in Human and Mouse.

LaMotte RH.

Adv Exp Med Biol. 2016;904:23-32. doi: 10.1007/978-94-017-7537-3_2.

10.

Contact immunotherapy enhances the therapeutic effects of nivolumab in treating in-transit melanoma: Two cases reports.

Fujimura T, Furudate S, Kakizaki A, Kambayashi Y, Haga T, Hashimoto A, Aiba S.

J Dermatol. 2016 Jun;43(6):686-9. doi: 10.1111/1346-8138.13229. Epub 2015 Dec 12.

PMID:
26663262
11.

Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.

Kehdy J, Erickson C, Rady P, Tyring S, Gaspari AA.

Cutis. 2015 Aug;96(2):114-8.

PMID:
26367749
12.

Squaric acid sensitization is not required for response in the treatment of alopecia areata.

Vedak P, Kroshinsky D.

J Am Acad Dermatol. 2015 Sep;73(3):471-6. doi: 10.1016/j.jaad.2015.04.064.

PMID:
26282797
13.

Psychophysical measurements of itch and nociceptive sensations in an experimental model of allergic contact dermatitis.

Pall PS, Hurwitz OE, King BA, LaMotte RH.

J Pain. 2015 Aug;16(8):741-9. doi: 10.1016/j.jpain.2015.04.009. Epub 2015 May 19.

14.

Treatment of alopecia areata with squaric acid dibutylester.

Hill ND, Bunata K, Hebert AA.

Clin Dermatol. 2015 May-Jun;33(3):300-4. doi: 10.1016/j.clindermatol.2014.12.001. Epub 2014 Dec 8. Review.

PMID:
25889130
15.

Efficacy of squaric acid dibutyl ester in treatment of recalcitrant warts in children.

Bagherani N.

Dermatol Ther. 2015 Sep-Oct;28(5):330. doi: 10.1111/dth.12234. Epub 2015 May 14. No abstract available.

PMID:
25817990
16.

Treatment of warts with contact allergens.

Word AP, Nezafati KA, Cruz PD Jr.

Dermatitis. 2015 Jan-Feb;26(1):32-7. doi: 10.1097/DER.0000000000000092. Review.

PMID:
25581668
17.

Treatment of alopecia areata with topical sensitizers.

Sutherland L, Laschinger M, Syed ZU, Gaspari A.

Dermatitis. 2015 Jan-Feb;26(1):26-31. doi: 10.1097/DER.0000000000000094. Review.

PMID:
25581667
18.

Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.

Avitabile S, Sordi D, Garcovich S, Colonna L, De Luca A, Nasorri F, Mazzanti C, Cavani A.

J Dermatol. 2015 Jan;42(1):98-9. doi: 10.1111/1346-8138.12740. Epub 2014 Dec 12. No abstract available.

PMID:
25495487
19.

Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.

Pandey S, Wilmer EN, Morrell DS.

Pediatr Dermatol. 2015 Jan-Feb;32(1):85-90. doi: 10.1111/pde.12387. Epub 2014 Jul 14.

PMID:
25040421
20.

Enhanced scratching elicited by a pruritogen and an algogen in a mouse model of contact hypersensitivity.

Fu K, Qu L, Shimada SG, Nie H, LaMotte RH.

Neurosci Lett. 2014 Sep 5;579:190-4. doi: 10.1016/j.neulet.2014.03.062. Epub 2014 Apr 3.

Supplemental Content

Loading ...
Support Center